全文获取类型
收费全文 | 1225篇 |
免费 | 50篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 12篇 |
妇产科学 | 2篇 |
基础医学 | 41篇 |
口腔科学 | 14篇 |
临床医学 | 70篇 |
内科学 | 703篇 |
皮肤病学 | 4篇 |
神经病学 | 29篇 |
特种医学 | 27篇 |
外科学 | 46篇 |
综合类 | 51篇 |
预防医学 | 116篇 |
眼科学 | 1篇 |
药学 | 121篇 |
中国医学 | 27篇 |
肿瘤学 | 11篇 |
出版年
2024年 | 3篇 |
2023年 | 8篇 |
2022年 | 10篇 |
2021年 | 14篇 |
2020年 | 12篇 |
2019年 | 12篇 |
2018年 | 22篇 |
2017年 | 9篇 |
2016年 | 10篇 |
2015年 | 23篇 |
2014年 | 68篇 |
2013年 | 76篇 |
2012年 | 108篇 |
2011年 | 111篇 |
2010年 | 61篇 |
2009年 | 60篇 |
2008年 | 89篇 |
2007年 | 111篇 |
2006年 | 87篇 |
2005年 | 76篇 |
2004年 | 62篇 |
2003年 | 52篇 |
2002年 | 32篇 |
2001年 | 24篇 |
2000年 | 26篇 |
1999年 | 19篇 |
1998年 | 16篇 |
1997年 | 8篇 |
1996年 | 11篇 |
1995年 | 11篇 |
1994年 | 6篇 |
1993年 | 3篇 |
1992年 | 2篇 |
1991年 | 3篇 |
1990年 | 4篇 |
1989年 | 4篇 |
1988年 | 4篇 |
1987年 | 4篇 |
1985年 | 5篇 |
1984年 | 2篇 |
1983年 | 1篇 |
1981年 | 3篇 |
1979年 | 1篇 |
1978年 | 3篇 |
1977年 | 2篇 |
1976年 | 1篇 |
1975年 | 1篇 |
1972年 | 1篇 |
1965年 | 1篇 |
排序方式: 共有1282条查询结果,搜索用时 15 毫秒
41.
42.
43.
Georgios Giannopoulos Georgios Oudatzis Georgios Paterakis Andreas Synetos Eleni Tampaki Georgios Bouras George Hahalis Dimitrios Alexopoulos Dimitrios Tousoulis Michael W. Cleman Christodoulos Stefanadis Spyridon Deftereos 《International journal of cardiology》2014
Background
Red blood cell and platelet microparticles (RBCm and PLTm, respectively) have drawn research attention as to their potential prothrombotic and vasoconstrictive effects in experimental settings. However, the relevance of circulating microparticles in clinical settings is largely undetermined.Methods
Circulating microparticles were quantified with a flow cytometric method in blood samples from consecutive STEMI patients after primary PCI. A matched cohort of healthy volunteers was used to derive reference values for comparison. STEMI patients were followed for 6 months for a composite clinical endpoint.Results
Fifty-one STEMI patients (age 59.8 ± 8.8 years) and 50 controls (age 56.2 ± 9.2 years; p = 0.155) were enrolled. RBCm concentration was 18,198 ± 6062/μl in the reference cohort versus 33,740 ± 21,169/μl in STEMI patients (p < 0.001). RBCm count was not correlated to total RBCs (standardized beta 0.018; p = 0.861). PLTm did not differ between groups (17,529 ± 16,292/μl in STEMI patients versus 14,372 ± 6211/μl in controls; p = 0.203). RBCm c-statistic was 0.832 (95% confidence interval 0.720 to 0.944), while PLTm prognostic value was not statistically significant (c-statistic 0.614, 95% confidence interval 0.444 to 0.784). In the multivariate analysis, RBCm concentration was independently associated with the occurrence of the clinical endpoint, after adjustment for age, ejection fraction, serum creatinine and presence of diabetes (adjusted p = 0.034).Conclusions
The present study demonstrates for the first time that erythrocyte microparticles are elevated in patients with STEMI treated with primary PCI, with levels approximately double those measured in a reference population of healthy volunteers, and their concentrations appear to be positively associated with adverse clinical events. 相似文献44.
45.
46.
47.
48.
49.
John Skoumas Catherine Liontou Christina Chrysohoou Constantina Masoura Konstantinos Aznaouridis Christos Pitsavos Christodoulos Stefanadis 《Atherosclerosis》2014
Objective
Controversial findings exist regarding potential influence of statin therapy on diabetic incidence. Aim of this study was to investigate the role of long duration statin treatment on diabetes mellitus (DM) incidence of Heterozygous Familial Hypercholesterolemia (hFH) and Familial Combined Hyperlipidemia (FCH) patients.Methods
Study population consisted of 212 hFH and 147 FCH patients that visited Lipid Outpatient Department (mean follow up of 11 and 10 years respectively). Several clinical data such as history of DM, cardiovascular disease, thyroid function, metabolic syndrome, glucose levels, lipid profile and lifestyle data were obtained. In order to compare the effects of different doses of different types of statins, a “statin treatment intensity product” was used.Results
14% of FCH and only 1% of hFH patients developed DM during follow up. Although univariate analysis showed a statistical trend (p = 0.06) in the association between new onset DM and statin treatment intensity (STI) in the FCH subgroup of patients with normal baseline glucose levels, this was no longer significant after adjusting for several confounders. Furthermore, the type of statins used did not seem to play a role in the development of DM either in hFH or FCH patients.Conclusion
Long duration of high STI does not seem to be associated with diabetic risk in hFH patients. High STI used in the FCH population is not associated with increased risk of new onset DM compared to low STI. Further studies are required in order to clarify the potential diabetogenic effects of statins in these high risk populations. 相似文献50.